Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine
about
Isolation and characterization of human apolipoprotein M-containing lipoproteinsModulation of paraoxonases during infectious diseases and its potential impact on atherosclerosisIon-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome.In vivo administration of BL-3050: highly stable engineered PON1-HDL complexesIs alcohol beneficial or harmful for cardioprotection?ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.Anti-oxidant properties of high-density lipoprotein and atherosclerosisBiochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis.Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction.HIV infection induces structural and functional changes in high density lipoproteins.Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport.Cholesterol Metabolism in CKDPON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery DiseaseEffect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.Increased Small Dense LDL and Decreased Paraoxonase Enzyme Activity Reveals Formation of an Atherogenic Risk in Streptozotocin-Induced Diabetic Guinea Pigs.There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study.Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study.Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.Dietary approaches to improving atheroprotective HDL functions.Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.Reduced glutathione increases quercetin stimulatory effects on HDL- or apoA1-mediated cholesterol efflux from J774A.1 macrophages.Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity.Cholesterol reduction and macrophage function: role of paraoxonases.Antiatherogenic activity of extracts of Argania spinosa L. pericarp: beneficial effects on lipid peroxidation and cholesterol homeostasis.The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.Paraoxonase-1 activity is related to Trichinella spiralis-induced hepatitis in rats.A high throughput serum paraoxonase assay for discovery of small molecule modulators of PON1 activity.The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study.HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF/MS-based metabolomics approach.High-density lipoprotein impedes glycation of low-density lipoprotein.HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease.Broad-spectrum antioxidant peptides derived from His residue-containing sequences present in human paraoxonase 1.Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.Phenol-enriched olive oils modify paraoxonase-related variables: A randomized, crossover, controlled trial.
P2860
Q24336276-C474FED3-887E-4F2B-99A3-9CE5C9D40295Q27004131-8E8010B1-8B80-402E-823A-FC58F76320BCQ30559384-FC54C499-E8F4-47E5-987C-F82E643521A2Q30891417-6727E2C3-EAF3-423B-AD0D-2ADAF7257BFEQ33911138-221DA9C2-5BB7-48A9-A683-E29377C9952CQ34112680-8203074E-FD33-4050-B698-F8F1EB07B9CBQ34440172-D6D3EA86-7C57-48CE-814A-AAC3A0A51FACQ35028691-8E44035F-D89E-46E2-9268-4DADCB37166AQ35572369-56AB1CF4-2981-4C24-9E80-21F592994329Q35615662-51D5481D-6EE9-4EE8-8C59-856E0AFFC5E9Q35741256-A3CCCF01-0DFA-4491-8274-555D521E2CBEQ36173726-2799DEDC-D736-43F5-A1DA-3B63A78FF149Q36302734-EB56BE62-A5B0-4897-8D86-E664B7727680Q36315574-C97A6480-0E06-466D-9A4C-ADB10E89D91CQ36366974-C578B250-74F8-4441-BFC7-5150653AF2D8Q36782847-E80F93FB-ED77-4DFE-B92E-F1FE94F339A6Q36825726-34F339EC-CC3E-43D7-B20A-C2AF034F7B74Q36996548-402F232E-268B-4E37-851D-A0BF24C69C8DQ37031558-448D0C44-9154-4DDF-9E09-3FD017F03015Q37165144-DA732778-EB61-4E84-B27E-EC613E5E0D00Q38127103-1A51AC8F-95B4-47F2-9904-674E9774B49BQ38724228-169ED0A9-7643-474D-828C-C902D5FCABB5Q38955607-99463825-4E3C-48B8-A133-5637BC541FF9Q38958121-0F0851B7-EF63-47E9-A518-0426E970465CQ39429336-23305126-4F19-45BB-AFA8-636198B3001EQ39457518-AC429F96-2825-448A-BB54-40A2CC83CF6BQ40038066-C7465BAA-8431-42A2-86FF-894862D39E7FQ40331033-2ABEB348-90CD-4AF3-A204-55218BB47A5FQ40365519-2B008A59-C4E2-44EA-868B-CDAC67D55FE1Q42941287-5D55AA6E-08E4-44F9-B287-4E210F545E5EQ43235426-06C68AE1-A620-4AFE-8924-EE77F9E4A565Q43260384-81E283E4-9B5F-473B-B445-7B1098417D56Q43757434-773CFF31-5F85-4DA0-9EE7-FDF3924A3ED4Q44036673-0AA9FE19-14F1-4C76-A0DA-F6EA450FDDD2Q46224865-560DE089-7DAD-44B0-B7E2-5B3CBD2CCCE3Q46835046-58ABE392-B2FF-49B9-A6CD-A4BDA74130CCQ46941197-8CAE8441-4398-40AA-8601-73703A8410DBQ46975817-40344A1F-E40C-4628-9912-525A3AD28C1AQ50927115-EFE773D3-03AF-4213-A55C-36BC134AAD67Q50979921-BBD55FEF-F130-48C9-8751-BA27356F415B
P2860
Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@ast
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@en
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@en-gb
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@nl
type
label
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@ast
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@en
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@en-gb
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@nl
prefLabel
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@ast
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@en
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@en-gb
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@nl
P2093
P921
P3181
P1433
P1476
Paraoxonase 1 (PON1) enhances ...... le for lysophosphatidylcholine
@en
P2093
Diana Shih
Jacob Vaya
Michael Aviram
Mira Rosenblat
P3181
P356
10.1016/J.ATHEROSCLEROSIS.2004.10.028
P407
P577
2005-03-01T00:00:00Z